Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-12-11 13:43 Tx date 2023-12-08 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
780,752 | |
Filed 2023-03-09 18:40 Tx date 2023-03-07 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,000
+80,000 vol $0.30 each |
80,000 | |
Filed 2023-01-10 19:50 Tx date 2022-12-30 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$60,000
+400,000 vol $0.15 each |
1,450,000 | |
Filed 2023-01-10 19:49 Tx date 2022-12-30 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-400,000 vol $0.15 each |
104,000 | |
Filed 2022-12-13 21:12 Tx date 2022-12-12 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$350,000
+1,000,000 vol $0.35 each |
1,000,000 | |
Filed 2022-12-13 21:11 Tx date 2022-12-12 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-12-13 21:11 Tx date 2022-12-12 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-21 14:19 Tx date 2022-03-15 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$83,750
+250,000 vol $0.335 each |
250,000 | |
Filed 2022-03-17 17:30 Tx date 2022-03-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$83,750
+250,000 vol $0.335 each |
||
Filed 2022-03-17 17:30 Tx date 2022-03-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$83,750
+250,000 vol $0.335 each |
250,000 | |
Filed 2022-03-17 17:29 Tx date 2022-02-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-17 17:28 Tx date 2022-02-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-11-04 11:11 Tx date 2021-10-29 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$54,902
+274,510 vol $0.20 each |
1,014,020 | |
Filed 2021-11-04 11:10 Tx date 2021-10-29 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-274,510 vol |
0 | |
Filed 2021-10-19 15:40 Tx date 2020-05-13 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
Filed 2021-09-05 16:28 Tx date 2020-02-27 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
||
Filed 2021-10-18 16:33 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
903,760 | |
Filed 2021-10-15 11:02 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
||
Filed 2021-10-15 15:12 Tx date 2020-11-20 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-323,008 vol |
580,752 | |
Filed 2021-10-15 11:02 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
903,760 | |
Filed 2021-09-05 16:28 Tx date 2020-02-27 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
Filed 2021-09-05 16:26 Tx date 2020-02-27 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-31 21:43 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$37,500
+250,000 vol $0.15 each |
250,000 | |
Filed 2021-08-31 21:42 Tx date 2020-05-13 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+50,000 vol $0.15 each |
300,000 | |
Filed 2021-08-31 21:41 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
||
Filed 2021-08-31 21:33 Tx date 2018-09-17 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-31 21:29 Tx date 2020-05-13 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+200,000 vol $0.15 each |
700,000 | |
Filed 2021-08-31 21:28 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
500,000 | |
Filed 2021-08-31 21:27 Tx date 2019-02-28 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-19 20:00 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
504,000 | |
Filed 2021-07-06 11:51 Tx date 2021-07-02 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+5,000 vol |
5,000 | |
Filed 2021-07-06 11:48 Tx date 2020-02-27 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-06 11:48 Tx date 2021-07-02 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,000
+10,000 vol $0.50 each |
30,000 | |
Filed 2021-04-06 14:41 Tx date 2021-04-01 |
$TELO
Telo Genomics Corp. |
Ross, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-04-06 14:40 Tx date 2021-04-01 |
$TELO
Telo Genomics Corp. |
Ross, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,000
+100,000 vol $0.64 each |
100,000 | |
Filed 2021-04-06 14:40 Tx date 2021-04-01 |
$TELO
Telo Genomics Corp. |
Ross, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-25 14:42 Tx date 2021-03-25 |
$TELO
Telo Genomics Corp. |
Cheung, Ryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$7,500
+50,000 vol $0.15 each |
500,000 | |
Filed 2020-12-07 21:51 Tx date 2020-11-30 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+200,000 vol |
1,050,000 | |
Filed 2020-12-07 21:51 Tx date 2020-11-30 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-200,000 vol |
0 | |
Filed 2020-10-28 15:48 Tx date 2020-10-28 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,600
+20,000 vol $0.18 each |
20,000 | |
Filed 2020-10-28 15:47 Tx date 2020-02-27 |
$TELO
Telo Genomics Corp. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-21 19:27 Tx date 2020-10-21 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,850
+15,000 vol $0.19 each |
739,510 | |
Filed 2019-11-29 17:06 Tx date 2019-11-25 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Holder: Hugh Rogers Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-193,805 vol |
48,451 | |
Filed 2019-11-29 16:35 Tx date 2019-11-25 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-9,441,736 vol |
2,360,433 | |
Filed 2019-11-29 16:30 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$45,000
+450,000 vol $0.10 each |
2,810,433 | |
Filed 2019-11-29 14:57 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
30 - Acquisition or disposition under a purchase/ownership plan
|
$54,902
+274,510 vol $0.20 each |
274,510 | |
Filed 2019-11-29 14:56 Tx date 2018-09-17 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-29 14:56 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$27,451
+274,510 vol $0.10 each |
724,510 | |
Filed 2019-11-29 14:53 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$40,000
+200,000 vol $0.20 each |
200,000 | |
Filed 2019-11-29 14:51 Tx date 2018-09-25 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-29 14:40 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$40,000
+400,000 vol $0.10 each |
850,000 | |
Filed 2019-11-29 13:53 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$45,000
+450,000 vol $0.10 each |
450,000 | |
Filed 2019-11-29 13:52 Tx date 2018-09-25 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-29 13:49 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$45,000
+450,000 vol $0.10 each |
450,000 | |
Filed 2019-11-29 13:48 Tx date 2018-09-17 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-26 12:02 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Cheung, Ryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$45,000
+450,000 vol $0.10 each |
450,000 | |
Filed 2019-11-26 12:01 Tx date 2018-09-17 |
$TELO
Telo Genomics Corp. |
Cheung, Ryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-26 11:59 Tx date 2019-11-25 |
$TELO
Telo Genomics Corp. |
Savage, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$6,000
+300,000 vol $0.02 each |
542,256 |